STERIS plc (NYSE:STE) Q4 2024 Earnings Conference Call May 9, 2024 9:00 AM ET Company Participants Julie Winter - VP, IR Mike Tokich - SVP and CFO Dan Carestio - President and CEO Conference Call Participants Patrick Wood - Morgan Stanley Brett Fishbin - KeyBanc Mike Matson - Needham & Company Jason Bednar - Piper Sandler Operator Good day, and welcome to the STERIS plc Fourth Quarter 2024 Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note, this event is bei ...

STERIS plc (STE) reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.41, up 4.8% from the year-ago quarter’s figure. The figure matched the Zacks Consensus Estimate.The adjustment excludes the impacts of certain non-recurring charges like the amortization of acquired intangible assets and acquisition and integration-related charges, among others.The company’s GAAP net loss was 1 cent against the year-ago EPS of $1.88.  Revenues in DetailRevenues of $1.42 billion from continuing opera ...

Steris (STE) reported $1.42 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 2.5%. EPS of $2.41 for the same period compares to $2.30 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.46 billion, representing a surprise of -3.07%. The company has not delivered EPS surprise, with the consensus EPS estimate being $2.41.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...

Steris (STE) came out with quarterly earnings of $2.41 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.30 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this medical products maker would post earnings of $2.17 per share when it actually produced earnings of $2.22, delivering a surprise of 2.30%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Steris, which belongs to th ...

Exhibit 99.1 "We are pleased with the strong finish to the fiscal year, as our Healthcare segment continued their trend of outperformance, driven primarily by strength in the United States," said Dan Carestio, President and CEO of STERIS. "We have made several strategic decisions in fiscal 2024 that will position STERIS for future growth, including today's targeted restructuring announcement and the announcement to divest the Dental segment. Heading into fiscal 2025, I am confident in our ability to deliver ...

Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billio ...

STERIS plc (STE) is likely to grow in the coming quarters, backed by the promising recovery potential in the AST (Applied Sterilization Technologies) segment. The company also benefits from the growing healthcare and pharmaceutical sectors, fueled by an aging population and strategic acquisitions like the BD assets purchase. Strong solvency buoys optimism.Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges raise worry for the stock.In the past year, shares of this Zacks Rank #3 ...

STERIS plc (STE) is expected to release fourth-quarter fiscal 2024 results soon.Earnings Surprise HistorySTE has a strong earnings surprise history. The company beat earnings estimates in three of the trailing four quarters and missed once, the average surprise being 3.96%.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.22, which exceeded the Zacks Consensus Estimate by 2.30%.Let’s look at how things have shaped up before this announcement.Factors at PlayHealthcareTh ...

AUSTIN, Texas, April 11, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to acquire the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS"). Founded in 1908, HuFriedyGroup is a leading global manufacturer of high-quality instruments, infection prevention products, instrument management systems, and conscious sedation products for the dental industry. ...

A downtrend has been apparent in Steris (STE) lately with too much selling pressure. The stock has declined 9.1% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting w ...